Clinical Trial Update: Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial compared exemestane, letrozole, and anastrozole as adjuvant therapy in postmenopausal women undergoing surgery for Stage II or Stage III breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Aromasin (exemestane)
• FEMARA (letrozole)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-03-30